Serdar Arici
Overview
Explore the profile of Serdar Arici including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atci M, Secmeler S, Sakin A, Arici S, Can O, Selvi O, et al.
Indian J Cancer
. 2025 Feb;
61(4):714-721.
PMID: 39960699
Background: We aimed to evaluate the data of perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy regimen in locally advanced gastric cancer (LAGC) patients with real-life experience. Methods: In this...
2.
Kutlu Y, Cekin R, Goktas Aydin S, Shbair A, Bilici A, Arici S, et al.
Curr Probl Cancer
. 2024 May;
50:101102.
PMID: 38735211
Loss of human epidermal growth factor receptor 2 (HER2) expression can be seen in almost 25-30 % patients after HER2 receptor directed neoadjuvant treatment. These patients have unclear clinical outcomes...
3.
Guven O, Karyagar S, Arici S, Ozulker T, Can O
Nucl Med Commun
. 2023 Jun;
44(9):816-824.
PMID: 37334538
Purpose: To evaluate whether metabolic and volumetric data from 68 Ga-PSMA PET/CT performed during staging of de-novo high-volume mCSPC patients who received docetaxel could be used to predict survival. Methods:...
4.
Emirzeoglu L, Arici S, Sahin A, Ocak B, Ak N, Ay S, et al.
Breast Care (Basel)
. 2023 Mar;
18(1):42-48.
PMID: 36876171
Purpose: The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish patients with local and locally...
5.
Ay S, Ozyukseler D, Basak M, Dulgar O, Arici S, Yildirim M, et al.
Ginekol Pol
. 2021 Jun;
PMID: 34105739
Objectives: Ovarian cancer is associated with the highest mortality of gynecologic cancers. Epidemiological and genetic factors of ovarian cancer development are clearly defined but prognostic factors have not been adequately...
6.
Sakin A, Atci M, Aldemir M, Akagunduz B, Sahin S, Arici S, et al.
Cureus
. 2021 May;
13(4):e14639.
PMID: 34046274
Objective In this study, we aimed to investigate the prognostic value of postoperative lymph node ratio (LNR)in locally advanced gastric cancer (GC) patients receiving neoadjuvant chemotherapy (NACT). Methods LNR was...
7.
Karyagar S, Guven O, Saglampinar Karyagar S, Arici S, Selvi O, Geredeli C, et al.
Nucl Med Commun
. 2021 May;
42(9):1011-1016.
PMID: 33958536
Objective: In patients with metastatic castration-resistant prostate cancer (mCRPCa), enzalutamide is administered when docetaxel treatment fails. The purpose of the study was to evaluate the relationship between prostate-specific antigen (PSA)...
8.
Atci M, Geredeli C, Ay S, Sakin A, Erturk B, Secmeler S, et al.
Eur J Breast Health
. 2021 Apr;
17(2):123-127.
PMID: 33870111
Objective: This study aimed to determine the differences in clinicopathological features of Turkish patients with high-risk breast cancer based on the mutation status of two breast cancer susceptibility genes (BRCA1/2)...
9.
Sakin A, Sengul Samanci N, Secmeler S, Arici S, Can O, Yasar N, et al.
J Cancer Res Ther
. 2020 Dec;
16(Supplement):S176-S182.
PMID: 33380674
Introduction: Obesity has become one of the major public health problems in many countries. Controversial results were reported in publications on the relationship between obesity and mortality in patients diagnosed...
10.
Arici S, Sakin A, Cekin R, Secmeler S, Yasar N, Cihan S
Oncol Res Treat
. 2020 Nov;
44(1-2):12-19.
PMID: 33242864
Introduction: The length of the necessary waiting period to test driver mutations may generate anxiety in patients and clinicians. For this reason, an investigation was conducted to determine whether the...